Skip to main content
. 2021 Jul 27;13(8):1144. doi: 10.3390/pharmaceutics13081144

Figure 13.

Figure 13

(a) PTX-ss-C18 prodrug of paclitaxel (PTX) can self-assemble as nanoparticles (PSNPs) that upon functionalization of their surface with Pep-PEG-DSPE (Pep-PSNPs) target glioma cells via interleukin 13 receptor α2-mediated endocytosis, releasing PTX into the glioma cells. (b) Upon functionalization of the PSPNPs surface with CGKRK-PEG-DSPE, CGKRK-PSNPs can enter glioma cells via heparan sulphate-mediated endocytosis. In both cases, the reducing environment of tumor cells allows the cleavage of the disulfide linker and the release of the free drug into glioma cells.